Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$1.25 - $1.94 $15,658 - $24,302
-12,527 Reduced 22.29%
43,662 $73,000
Q3 2022

Nov 14, 2022

SELL
$1.19 - $2.06 $8,501 - $14,716
-7,144 Reduced 11.28%
56,189 $69,000
Q1 2022

May 16, 2022

BUY
$2.02 - $3.92 $101,965 - $197,873
50,478 Added 392.67%
63,333 $156,000
Q4 2021

Feb 14, 2022

BUY
$3.74 - $6.7 $7,801 - $13,976
2,086 Added 19.37%
12,855 $48,000
Q3 2021

Nov 15, 2021

BUY
$6.05 - $10.41 $65,152 - $112,105
10,769 New
10,769 $68,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $375M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.